Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceThe impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectivesMathematical Modelling to Guide Drug Development for Malaria EliminationImpact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidenceModelling malaria control.Mathematical models for a new era of malaria eradicationReducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategiesHigh prevalence of drug resistance in animal trypanosomes without a history of drug exposureCost analysis of school-based intermittent screening and treatment of malaria in KenyaModelling the epidemiological impact of intermittent preventive treatment against malaria in infants.Application of loop analysis for evaluation of malaria control interventions.Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Intermittent preventive treatment for malaria in sub-saharan African: a halfway technology or a critical intervention?Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant womenIntermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.Malaria associated symptoms in pregnant women followed-up in BeninThe effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania.How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM studyIntermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.A stochastic model of immune-modulated malaria infection and disease in children.Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spreadRelation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese childrenCompetitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.Existing antimalarial agents and malaria-treatment strategies.Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges.Intermittent preventive treatment against malaria: an update.Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance.A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials.Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children.Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal.Superinfection and the evolution of resistance to antimalarial drugs.Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western KenyaThe Impact of Antimalarial Use on the Emergence and Transmission of Plasmodium falciparum Resistance: A Scoping Review of Mathematical ModelsEmerging implications of policies on malaria treatment: genetic changes in the gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa
P2860
Q21032450-73850AD4-8759-4AD9-86E7-57A408282C1EQ27344985-79DE7AC4-6058-4B3F-AE56-069C3012D3CFQ28067367-E2DD23FB-EBD3-4DF7-BA4E-3F1B85BC9BA5Q28222513-C1DFAF8F-43AF-44DC-AC07-F45A74F89013Q28468756-7F64876B-10D3-418A-AEF3-2E4EA8BE2EAEQ28474133-9BD6FC33-D9A7-4FF0-8220-787F74FEC466Q28475084-EEA5FD8B-C27D-4979-B48C-32DE1AEC288BQ28478493-477E875E-2681-4F56-A493-43D4B68B5780Q28744234-2E805A29-54B6-4748-BD04-2EEE9555206EQ33351939-DC8FC33B-CD02-4F17-B63B-6FA0844F929DQ33597968-4585408E-0F80-462A-B8DC-699E3D6FF4E3Q33645358-57A69FE2-1AC3-4566-81C3-96D86336A47DQ33817498-15A16E08-1AD6-440A-B600-60D2C830E99CQ33817503-4AE84FE6-72BC-4CBE-BB2B-728805E015FEQ34034202-7A12E475-7D76-4BFC-AB00-F199CBE80ECEQ34410295-38637A75-1040-4F1A-AC87-487D7EF225C1Q34790559-809B92DD-6F6F-421D-892D-5B2C7A652688Q34894294-7A7BBF5A-7BA4-412C-A26B-85B59EDED9DAQ34960038-7F67249B-702D-4559-B4B2-6C274A118E60Q35583501-83D0FB79-C864-4ADE-9EEE-4AB772200DAAQ35802773-0825CC11-2452-41C9-B844-25512856F4A4Q36094775-A6FC27D6-515C-4C4A-AA5F-F811B0C4B1FAQ36325249-C93EAA5C-9E94-4425-84BD-1696E14ABEF6Q36608075-63ADD715-27BC-41CA-99FD-6AC2DCC7F3D3Q36722524-DC6AC585-D6E4-4C2E-A4DF-993BFC548C5CQ36936686-85E9AAA1-29AF-4C3A-9654-3022F2C8D0F8Q37211417-F1318F5B-7048-4C0B-901D-6850D89950FBQ37492591-80648FBA-475F-45C4-B4A6-1DB7700C8473Q37738205-6D74100F-D675-4DE8-9A64-AE3CDBB45FA7Q37747411-0C7C7890-0C72-4E6F-8B05-87DF565E0486Q38868215-714F8990-6C60-42AD-8B6B-82FFB79EBCE3Q39345222-439296FA-390D-4C87-9971-6156424DE8CBQ47169530-EC82A1C9-758A-440D-9D45-20B7D5B3B64AQ47857941-F471CDE8-B7A5-4C1B-8D6B-5BA3D5DDACFDQ47969205-9CAF1635-1B75-4B6A-B085-141619E80E18Q51344705-32F7FDDB-6313-47AC-97C6-973C665B2F1BQ56362320-3CF059A7-54D6-4913-871B-D4D7CF742091Q57151906-F5A1A542-0DE5-4C95-A41C-3D2F45317927Q58586501-78CF861D-BB55-46C4-A565-DE05C28B35C0
P2860
Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Potential impact of intermitte ...... read of drug-resistant malaria
@ast
Potential impact of intermitte ...... read of drug-resistant malaria
@en
Potential impact of intermitte ...... read of drug-resistant malaria
@nl
type
label
Potential impact of intermitte ...... read of drug-resistant malaria
@ast
Potential impact of intermitte ...... read of drug-resistant malaria
@en
Potential impact of intermitte ...... read of drug-resistant malaria
@nl
prefLabel
Potential impact of intermitte ...... read of drug-resistant malaria
@ast
Potential impact of intermitte ...... read of drug-resistant malaria
@en
Potential impact of intermitte ...... read of drug-resistant malaria
@nl
P2860
P1433
P1476
Potential impact of intermitte ...... read of drug-resistant malaria
@en
P2093
F Ellis McKenzie
Wendy Prudhomme O'Meara
P2860
P356
10.1371/JOURNAL.PMED.0030141
P407
P577
2006-04-04T00:00:00Z